These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 25625240)
1. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240 [TBL] [Abstract][Full Text] [Related]
2. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis. Huang X; Sheng Y; Guan M Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data. Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019 [TBL] [Abstract][Full Text] [Related]
4. CD133 mRNA expression and microsatellite instability in colorectal carcinoma. Huh JW; Park YS; Lee JH; Kim HR; Shin MG; Kim YJ J Surg Oncol; 2010 Dec; 102(7):765-70. PubMed ID: 20872808 [TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer. Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798 [TBL] [Abstract][Full Text] [Related]
6. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors. Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer. Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients. Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242 [TBL] [Abstract][Full Text] [Related]
9. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer. Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis. Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326 [TBL] [Abstract][Full Text] [Related]
13. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment. Lönnroth C; Andersson M; Nordgren S; Lundholm K Int J Oncol; 2012 Jul; 41(1):15-23. PubMed ID: 22552364 [TBL] [Abstract][Full Text] [Related]
15. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258 [TBL] [Abstract][Full Text] [Related]
16. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study. Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. Nakamura K; Iinuma H; Aoyagi Y; Shibuya H; Watanabe T Oncology; 2010; 78(5-6):309-15. PubMed ID: 20616575 [TBL] [Abstract][Full Text] [Related]
18. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Le H; Zeng F; Xu L; Liu X; Huang Y Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862 [TBL] [Abstract][Full Text] [Related]
19. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409 [TBL] [Abstract][Full Text] [Related]
20. Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer. Neumann J; Löhrs L; Albertsmeier M; Reu S; Guba M; Werner J; Kirchner T; Angele M Cancer Invest; 2015; 33(8):354-60. PubMed ID: 26068177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]